miR-143 inhibition increased HIF1A protein levels, promoted glioma cell invasion and DNA synthesis, and enhanced HUVEC tube formation, whereas OR7E156P silencing partially reversed the cellular effects of miR-143 inhibition. Here, HIF1A is linked to central nervous system cancer.